Muscle-Derived Cells for Treatment of Iatrogenic Sphincter Damage and Urinary Incontinence in Men

Figure 1

Immunostaining of cells prior to transplantation.

(a) Unstained cells

(b) 𝛼-sarcomeric actin positive cells (49.5%)

(c) Desmin positive cells (32.7%)

(d) 𝛼-smooth muscle actin positive cells (7.3%)

(e) MyoD1 positive cells ()

(f) Myotubes (blue dots) in 𝛼-sarcomeric actin positive cells (1.0%)